Delivery Order SPE2DB20D3303-SPE2DB25FA2HM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,502.36 to AmerisourceBergen Drug Corp for SPIRIVA RESPIMAT 1.25 MCG INH 4GM, a respiratory medication used in the treatment of chronic obstructive pulmonary disease. Awarded on July 23, 2025, with an ultimate completion date of July 24, 2025, this firm fixed-price delivery order represents a non-competitive set-aside procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,042.65 delivery order to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhalation medication (4 gm) with an ultimate completion date of August 1, 2025. This competitive award, utilizing firm fixed pricing, was issued with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,322.94 to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhaler (4 grams) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed price delivery order represents a non-competitive set-aside procurement and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SPIRIVA RESPIMAT 2.5 MCG inhalation medication in a 4 GM formulation, with a ceiling value of $1,779.64. This competitively awarded, firm fixed-price delivery order was issued on July 29, 2025, with an ultimate completion date of July 30, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,086.40 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation medication (4 grams) on July 29, 2025, with completion scheduled for July 30, 2025. This firm fixed-price, non-set-aside contract is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $2,982.05 to AmerisourceBergen Drug Corp for SPIRIVA RESPIMAT 2.5 MCG inhalation medication in 4GM quantity. This non-competitive, firm fixed-price delivery order was awarded on May 15, 2025, with an ultimate completion date of May 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,097.88 to AmerisourceBergen Drug Corp for SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory maintenance medication, with an ultimate completion date of July 30, 2025. The award, issued on July 29, 2025, utilizes firm fixed price pricing and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SPIRIVA RESPIMAT 1.25 mcg inhalation solution (4 gm) on July 22, 2025, with a ceiling value of $2,903.48. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded procurement. The order is set for completion by July 23, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Spiriva Respimat 2.5 mcg inhalation medication in 4-gram quantities, with a ceiling value of $1,277.09. This firm fixed-price delivery order, which must be completed by August 15, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,158.44 to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhalation medication in 4-gram units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and due for completion by July 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2HMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,086.49 to AmerisourceBergen Drug Corp for SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication used to treat chronic obstructive pulmonary disease. Issued on August 8, 2025, with a completion deadline of August 11, 2025, this firm fixed price delivery order represents a routine pharmaceutical procurement under a non-competitive set-aside arrangement. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution operations. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. This comprehensive pharmaceutical vehicle enables AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen has consistently won competitively awarded contracts with DLA across multiple therapeutic domains, positioning it as a primary supplier for Department of Defense healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 8/8/25 |